In our study, the plasma biomarker collection, cognitive evaluation and neuroimaging studies were performed around 3 months after stroke, and we found the plasma Aβ42/Aβ40 ratio and tau-related composite scores were correlated with PSCI presentations. Here, MAPT is linked to stroke disorder.